These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 17649778)
21. Malignant peripheral nerve sheath tumour of the cervical vagus nerve in a neurofibromatosis type 1 patient. Molina AR; Brasch H; Tan ST J Plast Reconstr Aesthet Surg; 2006; 59(12):1458-62. PubMed ID: 17113542 [TBL] [Abstract][Full Text] [Related]
22. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Ferner RE; Gutmann DH Cancer Res; 2002 Mar; 62(5):1573-7. PubMed ID: 11894862 [TBL] [Abstract][Full Text] [Related]
23. Brachial plexopathy due to malignant peripheral nerve sheath tumor in neurofibromatosis type 1: case report and subject review. Pacelli J; Whitaker CH Muscle Nerve; 2006 May; 33(5):697-700. PubMed ID: 16323217 [TBL] [Abstract][Full Text] [Related]
24. Dysplasia of the orbit and adjacent bone associated with plexiform neurofibroma and ocular disease in 42 NF-1 patients. Friedrich RE; Stelljes C; Hagel C; Giese M; Scheuer HA Anticancer Res; 2010 May; 30(5):1751-64. PubMed ID: 20592374 [TBL] [Abstract][Full Text] [Related]
25. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Waggoner DJ; Towbin J; Gottesman G; Gutmann DH Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438 [TBL] [Abstract][Full Text] [Related]
26. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142 [TBL] [Abstract][Full Text] [Related]
28. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676 [TBL] [Abstract][Full Text] [Related]
29. Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Mautner VF; Friedrich RE; von Deimling A; Hagel C; Korf B; Knöfel MT; Wenzel R; Fünsterer C Neuroradiology; 2003 Sep; 45(9):618-25. PubMed ID: 12898075 [TBL] [Abstract][Full Text] [Related]
30. [Unilateral facial and cerebral hyperplasia associated with neurofibromatosis type 1. Report of four patients]. Pascual-Castroviejo I; Pascual-Pascual SI; Burgueno M; Martin-Perez M; Palencia R; Garcia-Segura JM; Valero C Rev Neurol; 2006 Sep 16-30; 43(6):346-52. PubMed ID: 16981165 [TBL] [Abstract][Full Text] [Related]
31. Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. Adamson DC; Cummings TJ; Friedman AH Clin Neuropathol; 2004; 23(5):245-55. PubMed ID: 15581029 [TBL] [Abstract][Full Text] [Related]
32. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings. Spurlock G; Knight SJ; Thomas N; Kiehl TR; Guha A; Upadhyaya M J Cancer Res Clin Oncol; 2010 Dec; 136(12):1869-80. PubMed ID: 20229272 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379 [TBL] [Abstract][Full Text] [Related]
34. Recurrent malignant peripheral nerve sheath tumour in a patient with neurofibromatosis Type 1: a case report. Dimou J; Jithoo R; Pitcher M; White G J Clin Neurosci; 2009 Sep; 16(9):1221-3. PubMed ID: 19539475 [TBL] [Abstract][Full Text] [Related]
35. Giant malignant peripheral nerve sheath tumor of the scalp. F T; A M M A; B A de L; T C C C; R C L; G H T S B; H C Acta Neurol Taiwan; 2012 Sep; 21(3):133-5. PubMed ID: 23196734 [TBL] [Abstract][Full Text] [Related]
36. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. McCaughan JA; Holloway SM; Davidson R; Lam WW J Med Genet; 2007 Jul; 44(7):463-6. PubMed ID: 17327286 [TBL] [Abstract][Full Text] [Related]
37. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850 [TBL] [Abstract][Full Text] [Related]
38. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors. Friedrich RE; Nörnberg LKN; Hagel C Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721 [TBL] [Abstract][Full Text] [Related]
39. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330 [TBL] [Abstract][Full Text] [Related]